TERT and hereditary chronic pancreatitis: TERT promoter mutations have been identified in CNS SFT/HPC, but specific data in this setting are limited.[32, 33] In our cases, we observed a lower overall mutation rate compared to previously reported data (16.7% versus 25.6%), a difference even greater when considering the HPC phenotype alone (16.7% versus 50%).[32] We did not observe an association between TERT promoter mutational status and outcome, but this could probably be explained by the limited sample size.